1. Home
  2. INO vs SNCR Comparison

INO vs SNCR Comparison

Compare INO & SNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INO
  • SNCR
  • Stock Information
  • Founded
  • INO 1979
  • SNCR 2000
  • Country
  • INO United States
  • SNCR United States
  • Employees
  • INO N/A
  • SNCR N/A
  • Industry
  • INO Medical/Dental Instruments
  • SNCR EDP Services
  • Sector
  • INO Health Care
  • SNCR Technology
  • Exchange
  • INO Nasdaq
  • SNCR Nasdaq
  • Market Cap
  • INO 69.3M
  • SNCR 70.9M
  • IPO Year
  • INO 1998
  • SNCR 2006
  • Fundamental
  • Price
  • INO $2.18
  • SNCR $6.20
  • Analyst Decision
  • INO Buy
  • SNCR Strong Buy
  • Analyst Count
  • INO 5
  • SNCR 1
  • Target Price
  • INO $8.80
  • SNCR $13.00
  • AVG Volume (30 Days)
  • INO 2.1M
  • SNCR 62.9K
  • Earning Date
  • INO 11-13-2025
  • SNCR 11-11-2025
  • Dividend Yield
  • INO N/A
  • SNCR N/A
  • EPS Growth
  • INO N/A
  • SNCR N/A
  • EPS
  • INO N/A
  • SNCR N/A
  • Revenue
  • INO $182,337.00
  • SNCR $171,870,000.00
  • Revenue This Year
  • INO N/A
  • SNCR $1.51
  • Revenue Next Year
  • INO $15,960.33
  • SNCR $5.43
  • P/E Ratio
  • INO N/A
  • SNCR N/A
  • Revenue Growth
  • INO N/A
  • SNCR 2.54
  • 52 Week Low
  • INO $1.30
  • SNCR $5.25
  • 52 Week High
  • INO $7.00
  • SNCR $15.46
  • Technical
  • Relative Strength Index (RSI)
  • INO 47.09
  • SNCR 50.58
  • Support Level
  • INO $2.33
  • SNCR $5.41
  • Resistance Level
  • INO $2.98
  • SNCR $6.27
  • Average True Range (ATR)
  • INO 0.20
  • SNCR 0.30
  • MACD
  • INO -0.07
  • SNCR 0.10
  • Stochastic Oscillator
  • INO 2.44
  • SNCR 84.07

About INO Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

Share on Social Networks: